英国 suspected LGA 胎儿预防肩难产:引产与标准护理比较(Big Baby 试验)
这项在英格兰、苏格兰和威尔士106家医院开展的多中心、开放标签、随机对照3期试验,纳入2893名孕35+0至38+0周超声怀疑大于胎龄儿(估计胎儿体重>90th定制百分位)的孕妇,1:1随机分为标准护理组或38+0至38+4周引产组。意向性分析中,引产组肩难产33/1445(2·3%)vs 标准护理组44/1439(3·1%),RR 0·75(95%CI 0·51–1·09),P=0·14,无显著差异。符合方案分析中,引产组27/1180(2·3%)vs 标准护理组40/1074(3·7%),RR 0·62(95%CI 0·41–0·92),P=0·019,引产组显著降低。引产组不良事件88/1447(6·1%)vs 标准护理组108/1446(7·5%),RR 0·81(95%CI 0·62–1·06),P=0·13,无显著差异。
要点
- 意向性分析:引产组肩难产2·3%(33/1445)vs 标准护理组3·1%(44/1439),RR 0·75(95%CI 0·51–1·09),P=0·14,无显著差异。
- 符合方案分析:引产组肩难产2·3%(27/1180)vs 标准护理组3·7%(40/1074),RR 0·62(95%CI 0·41–0·92),P=0·019,引产显著降低。
- 标准护理组24·6%(355/1446)在38+4周前自然临产、引产或分娩,削弱了组间孕周和出生体重差异。
- 两组不良事件无显著差异:引产组6·1%(88/1447)vs 标准护理组7·5%(108/1446),RR 0·81(95%CI 0·62–1·06),P=0·13。
- 引产组新生儿死亡1例(脓毒症和先天性肺炎后),标准护理组新生儿死亡1例(肩难产后围产期窒息)。
适用人群与场景
- 年龄≥18岁、孕35+0至38+0周超声怀疑大于胎龄儿(估计胎儿体重>90th定制百分位)的孕妇。
- 排除:药物治疗的糖尿病、妊娠期糖尿病、已计划或已有指征的择期剖宫产或引产。
- 招募自英格兰、苏格兰和威尔士106家医院。
诊断标准与关键阈值
- 大于胎龄儿疑似标准:超声估计胎儿体重>90th定制百分位,孕35+0至38+0周。
- 随机分组按估计胎儿体重百分位(≤95th或>95th)和母亲年龄(≤35岁或>35岁)分层。
处置流程与药物剂量
- 引产组:在孕38+0至38+4周之间进行引产。
- 标准护理组:按常规护理,不强制早期引产。
研究设计与关键结果
- 多中心、开放标签、随机对照3期试验,2893名孕妇随机分为引产组(n=1447)和标准护理组(n=1446);因标准护理组肩难产发生率低于预期,试验在达到4000例目标前终止。
- 意向性分析:引产组肩难产33/1445(2·3%)vs 标准护理组44/1439(3·1%),RR 0·75(95%CI 0·51–1·09),P=0·14;平均孕周差-6·0天(95%CI -6·3至-5·6),平均出生体重差-163·6 g(95%CI -190·0至-137·1)。
- 符合方案分析:引产组肩难产27/1180(2·3%)vs 标准护理组40/1074(3·7%),RR 0·62(95%CI 0·41–0·92),P=0·019;平均孕周差-8·1天(95%CI -8·4至-7·9),平均出生体重差-213·3 g(95%CI -242·0至-184·6)。
- 标准护理组24·6%(355/1446)在38+4周前已引产、分娩或临产。
- 不良事件:引产组88/1447(6·1%)vs 标准护理组108/1446(7·5%),RR 0·81(95%CI 0·62–1·06),P=0·13;严重不良事件两组相似。
- 新生儿死亡:标准护理组1例死于肩难产后围产期窒息,引产组1例死于脓毒症和先天性肺炎。
证据类型、等级与局限
- 证据类型:多中心、开放标签、随机对照3期试验(Big Baby trial)。
- 局限:试验提前终止(未达到4000例目标),标准护理组肩难产发生率低于预期。
对床旁实践的改变
- 作者认为,本研究为怀疑大于胎龄儿的孕妇及其临床医生关于分娩时机和方式的选择与决策提供了重要信息。
- 意向性分析未显示38+0至38+4周引产显著降低肩难产,但符合方案分析显示显著降低;临床决策需结合个体情况。
指南或共识出处
- Big Baby trial,注册号ISRCTN 18229892,由英国国家卫生与护理研究所(National Institute for Health and Care Research)健康技术评估项目资助。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The benefits and harms of early induction of labour to reduce shoulder dystocia in fetuses suspected to be large for gestational age (LGA) are uncertain. We aimed to investigate whether early induction of labour is associated with a reduced risk of shoulder dystocia compared with standard care.
METHODS: In this open-label, randomised controlled phase 3 trial, women aged ≥18 years with a suspected LGA fetus (estimated fetal weight >90th customised percentile) as identified by ultrasound scan between 35 weeks and 0 days (35+0 weeks) of gestation and 38+0 weeks' gestation, recruited from 106 hospitals across England, Scotland, and Wales in the UK, were randomly assigned (1:1) by web app to standard care or induction of labour between 38+0 weeks' gestation and 38+4 weeks' gestation using minimisation, balancing site, estimated fetal weight percentile (≤95th EFW percentile or >95th EFW percentile), and maternal age (≤35 years or >35 years). Key exclusion criteria included drug-treated diabetes, gestational diabetes, and elective caesarean section or induction already planned or indicated for any reason. Our primary outcome was incidence of shoulder dystocia, assessed by a masked independent expert adjudication panel who reviewed participants' delivery notes. Induction of labour was anticipated to result in birth 10·5 days earlier with a 300 g lower birthweight on average than standard care. We did an intention-to-treat (ITT) analysis in all participants for whom we had primary outcome data, and a per-protocol analysis in participants in the induction group who went into labour or were induced at 38+0 to 38+4 weeks' gestation versus participants in the standard care group who had not started labour, been induced, or had an elective caesarean section before 38+4 weeks' gestation. This study was registered with ISRCTN (18229892) and is no longer recruiting.
FINDINGS: Between June 8, 2018, and Oct 25, 2022, 2893 women were randomly assigned to induction of labour (n=1447) or standard care (n=1446); the trial was terminated before the target of 4000 participants was reached on advice of the data monitoring committee following the lower-than-expected incidence of shoulder dystocia in the standard care group. Two participants in the induction group and seven in the standard care group had missing data for the primary outcome and were excluded from the ITT analysis. In the ITT analysis, 33 (2·3%) of 1445 babies in the induction group versus 44 (3·1%) of 1439 in the standard care group had shoulder dystocia (risk ratio [RR] 0·75 [95% CI 0·51-1·09]; p=0·14) with a mean difference of -6·0 days' (95% CI -6·3 to -5·6) gestation and -163·6 g (-190·0 to -137·1) birthweight between trial groups. 355 (24·6%) of 1446 mothers in the standard care group were induced, delivered, or went into labour at or before 38+4 weeks' gestation. In the per-protocol analysis, 27 (2·3%) of 1180 babies in the induction group versus 40 (3·7%) of 1074 in the standard care group had shoulder dystocia (RR 0·62 [0·41-0·92]; p=0·019), and there was a mean difference of -8·1 days' (-8·4 to -7·9) gestation and -213·3 g (-242·0 to -184·6) birthweight between trial groups. One neonatal death occurred from perinatal asphyxia after shoulder dystocia in the standard care group, and one neonatal death occurred following sepsis and congenital pneumonia in the induction group. 88 (6·1%) of 1447 mothers in the induction group had an adverse event versus 108 (7·5%) of 1446 in the standard care group (RR 0·81 [0·62 to 1·06]; p=0·13). Similar numbers of serious adverse events were reported in both groups.
INTERPRETATION: No significant difference in incidence of shoulder dystocia was found between trial groups in the ITT analysis, probably due to the high proportion of earlier-than-expected deliveries in the standard care group reducing the intended between-group differences in gestational age and birthweight. However, in the per-protocol analysis, compared with all deliveries after 38+4 weeks' gestation, induction of labour between 38+0 weeks' gestation and 38+4 weeks' gestation did show a significant reduction in shoulder dystocia. This study provides pregnant women with suspected LGA fetuses and their clinicians important information about choices and decision making for timing and mode of birth.
FUNDING: National Institute for Health and Care Research Health Technology Assessment Programme.
参考来源
- Gardosi J, Ewington LJ, Booth K, et al. Induction of labour versus standard care to prevent shoulder dystocia in fetuses suspected to be large for gestational age in the UK (the Big Baby trial): a multicentre, open-label, randomised controlled trial. Lancet. 2025. PMID: 40319899. doi:10.1016/S0140-6736(25)00162-X
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。